🇺🇸 FDA
Pipeline program

Recombinant adeno-associated virus administration

HOPE-1

Phase 1 small_molecule terminated

Quick answer

Recombinant adeno-associated virus administration for Menkes Syndrome is a Phase 1 program (small_molecule) at Kunming Hope of Health Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Kunming Hope of Health Hospital
Indication
Menkes Syndrome
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials